Citigroup’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$433M Buy
4,033,057
+1,145,088
+40% +$123M 0.21% 57
2025
Q1
$291M Sell
2,887,969
-249,976
-8% -$25.2M 0.15% 91
2024
Q4
$280M Buy
3,137,945
+1,240,772
+65% +$111M 0.17% 74
2024
Q3
$159M Sell
1,897,173
-372,163
-16% -$31.2M 0.09% 135
2024
Q2
$175M Buy
2,269,336
+266,235
+13% +$20.5M 0.11% 124
2024
Q1
$137M Sell
2,003,101
-677,757
-25% -$46.4M 0.09% 145
2023
Q4
$155M Buy
2,680,858
+366,004
+16% +$21.2M 0.11% 99
2023
Q3
$122M Buy
2,314,854
+56,509
+3% +$2.98M 0.09% 126
2023
Q2
$122M Sell
2,258,345
-31,659
-1% -$1.71M 0.08% 133
2023
Q1
$115M Sell
2,290,004
-38,819
-2% -$1.94M 0.08% 138
2022
Q4
$108M Sell
2,328,823
-334,299
-13% -$15.5M 0.09% 148
2022
Q3
$103M Buy
2,663,122
+579,828
+28% +$22.5M 0.07% 154
2022
Q2
$77.6M Buy
2,083,294
+6,546
+0.3% +$244K 0.06% 189
2022
Q1
$92M Buy
2,076,748
+80,752
+4% +$3.58M 0.06% 207
2021
Q4
$84.8M Sell
1,995,996
-5,029,701
-72% -$214M 0.05% 233
2021
Q3
$305M Buy
7,025,697
+4,384,714
+166% +$190M 0.18% 61
2021
Q2
$113M Buy
2,640,983
+891,705
+51% +$38.1M 0.07% 202
2021
Q1
$67.6M Buy
1,749,278
+597,049
+52% +$23.1M 0.04% 287
2020
Q4
$41.4M Sell
1,152,229
-50,534
-4% -$1.82M 0.02% 399
2020
Q3
$46M Buy
1,202,763
+285,060
+31% +$10.9M 0.03% 303
2020
Q2
$32.2M Buy
917,703
+317,942
+53% +$11.2M 0.03% 352
2020
Q1
$19.6M Sell
599,761
-59,111
-9% -$1.93M 0.02% 430
2019
Q4
$29.8M Sell
658,872
-224,370
-25% -$10.1M 0.02% 429
2019
Q3
$35.9M Sell
883,242
-675,045
-43% -$27.5M 0.03% 340
2019
Q2
$67M Buy
1,558,287
+871,015
+127% +$37.4M 0.05% 213
2019
Q1
$26.4M Buy
687,272
+106,233
+18% +$4.08M 0.03% 386
2018
Q4
$20.5M Buy
581,039
+338,441
+140% +$12M 0.02% 449
2018
Q3
$9.34M Sell
242,598
-16,851
-6% -$649K 0.01% 731
2018
Q2
$8.49M Sell
259,449
-196,490
-43% -$6.43M 0.01% 814
2018
Q1
$12.5M Buy
455,939
+86,149
+23% +$2.35M 0.01% 619
2017
Q4
$9.17M Sell
369,790
-11,621
-3% -$288K 0.01% 714
2017
Q3
$11.1M Buy
381,411
+231,993
+155% +$6.77M 0.01% 655
2017
Q2
$4.14M Buy
149,418
+60,217
+68% +$1.67M ﹤0.01% 1041
2017
Q1
$2.22M Buy
89,201
+4,435
+5% +$110K ﹤0.01% 1348
2016
Q4
$1.83M Sell
84,766
-21,939
-21% -$474K ﹤0.01% 1930
2016
Q3
$2.54M Sell
106,705
-2,071
-2% -$49.3K ﹤0.01% 1257
2016
Q2
$2.54M Sell
108,776
-152,642
-58% -$3.57M ﹤0.01% 1139
2016
Q1
$4.92M Buy
261,418
+153,652
+143% +$2.89M 0.01% 835
2015
Q4
$1.99M Buy
107,766
+6,233
+6% +$115K ﹤0.01% 1358
2015
Q3
$1.67M Sell
101,533
-127,759
-56% -$2.1M ﹤0.01% 1421
2015
Q2
$4.06M Buy
229,292
+118,092
+106% +$2.09M ﹤0.01% 975
2015
Q1
$1.98M Sell
111,200
-189,477
-63% -$3.37M ﹤0.01% 1348
2014
Q4
$3.98M Sell
300,677
-182,960
-38% -$2.42M ﹤0.01% 935
2014
Q3
$5.71M Sell
483,637
-191,103
-28% -$2.26M 0.01% 812
2014
Q2
$8.62M Buy
674,740
+30,116
+5% +$385K 0.01% 645
2014
Q1
$8.71M Sell
644,624
-1,163,786
-64% -$15.7M 0.01% 611
2013
Q4
$21.7M Buy
1,808,410
+1,132,057
+167% +$13.6M 0.02% 350
2013
Q3
$7.94M Sell
676,353
-130,464
-16% -$1.53M 0.01% 700
2013
Q2
$7.48M Buy
+806,817
New +$7.48M 0.01% 698